FinTrust Capital Advisors’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

FinTrust Capital Advisors’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,000	Closed	-$2.47K	–	1454
2024 Q2	$2.47K	Hold	4,000	–	–	﹤0.01%	1166
2024 Q1	$10.3K	Hold	4,000	–	–	﹤0.01%	854
2023 Q4	$8.16K	Hold	4,000	–	–	﹤0.01%	865
2023 Q3	$6.88K	Hold	4,000	–	–	﹤0.01%	849
2023 Q2	$13.8K	Hold	4,000	–	–	﹤0.01%	717
2023 Q1	$13.8K	Hold	4,000	–	–	﹤0.01%	714
2022 Q4	$13.8K	Buy	+4,000	New	+$11.4K	﹤0.01%	711
2022 Q2	–	Sell	-200	Closed	-$1K	–	1331
2022 Q1	$1K	Hold	200	–	–	﹤0.01%	1197
2021 Q4	$3K	Buy	+200	New	+$2.21K	﹤0.01%	1087

Other funds holding GRTS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

FinTrust Capital Advisors's GRTS Position: Q3 2024 in Review

FinTrust Capital Advisors sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2024, closing a stake of 4,000 shares — an estimated $2.47K sold.

FinTrust Capital Advisors first reported a position in GRTS in Q4 2021 and held it in 9 quarters. The position peaked at $13.8K in Q2 2023. 56 funds tracked by Wall St. Rank hold GRTS as of Q3 2024.

FinTrust Capital Advisors reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
FinTrust Capital Advisors sold 4,000 Gritstone bio, Inc. Common Stock shares in Q3 2024, an estimated $2.47K.
FinTrust Capital Advisors first reported a position in Gritstone bio, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
FinTrust Capital Advisors's Gritstone bio, Inc. Common Stock position peaked at $13.8K in Q2 2023.
56 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2024.

Based on FinTrust Capital Advisors's 13F filing for Q3 2024, filed 11 Oct 2024.